Cases 1 - 7 of 7
Nevakar, Inc. v. Leiutis Pharmaceuticals Pvt Ltd et al
as 1:2021cv00133
Defendant:
GYMA Laboratories of America, Inc. and Leiutis Pharmaceuticals Pvt Ltd
Plaintiff:
Nevakar, Inc.
Cause Of Action: 28 U.S.C. § 1332
In re: Lorazepam & Clorazepate Antitr, et al v. Mylan Laboratories, Inc., et al
as 17-7136
In Re:
In re: Lorazepam & Clorazepate Antitrust Litigation
Plaintiff - Appellee:
Blue Cross & Blue Shield of Minnesota, a Minnesota Corpoation, Blue Cross & Blue Shield of Massachusetts, a Massachusetts Corporation, Federated Mutual Insurance Company, a Minnesota Corporation and others
Defendant - Appellee:
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc.
Defendant - Appellant:
Cambrex Corporation and Gyma Laboratories of America, Inc.
In re: Lorazepam & Clorazepate Antitr, et al v. Mylan Laboratories, Inc., et al
as 17-7135
In Re:
In re: Lorazepam & Clorazepate Antitrust Litigation
Plaintiff - Appellee:
Blue Cross & Blue Shield of Minnesota, a Minnesota Corpoation, Blue Cross & Blue Shield of Massachusetts, a Massachusetts Corporation, Federated Mutual Insurance Company, a Minnesota Corporation and others
Defendant - Appellant:
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc.
Defendant - Appellee:
Cambrex Corporation and Gyma Laboratories of America, Inc.
In Re: Aggrenox Antitrust Litigation
as 3:2014md02516
Defendant:
Teva Women's Health, Inc., Barr Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd. and others
In Re:
Aggrenox Antitrust Litigation
Plaintiff:
Pirelli Armstrong Retiree Medical Benefits Trust, Operating Engineers Local 312 Health and Welfare Trust, A.F. of L. - A.G.C. Buildings Trade Welfare Plan and others
Consolidated Plaintiff:
Louisiana Health Service Indemnity Company
Claimant:
Lonny DiTella
Interested Party:
Gyma Laboratories of America, Inc., PAR Pharmaceutical, Inc., Aetna Inc. and others
Amicus Curiae:
Generic Pharmaceutical Association
Cause Of Action: MDL 2516 In Re: Aggrenox Antitrust Litigation
In re: Lorazepam
as 08-5045
In Re:
In re: Lorazepam & Clorazepate Antitrust Litigation
Plaintiff - Appellee:
Federal Trade Commission, State of Florida, By Attorney General Robert A. Butterworth, State of Illinois, By Attorney General James E. Ryan and others
Defendant - Appellee:
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc.
Defendant - Appellant:
Gyma Laboratories of America, Inc. and Cambrex Corporation
In re: Lorazepam
as 08-5044
In Re:
In re: Lorazepam & Clorazepate Antitrust Litigation
Plaintiff - Appellee:
Federal Trade Commission, State of Florida, By Attorney General Robert A. Butterworth, State of Illinois, By Attorney General James E. Ryan and others
Defendant - Appellant:
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc.
Defendant - Appellee:
Gyma Laboratories of America, Inc. and Cambrex Corporation
In Re: LORAZEPAM/CLORAZE, et al v. MYLAN LABORATORIES, et al
as 1:1999mc00276
Plaintiff:
FEDERAL TRADE COMMISSION , STATE OF FLORIDA , STATE OF ILLINOIS and others
Defendant:
MYLAN LABORATORIES, INC. , CAMBREX CORPORATION , PROFARMACO S.R.L. and others
Movant:
AETNA US HEALTHCARE , CHAMBER OF COMMERCE OF THE UNITED STATES OF AMERICA , STEVEN ARONSON and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
